© 1994 Oxford University Press
research-article |
Chronic Toxicity Studies of Piperonyl Butoxide in F344 Rats: Induction of Hepatocellular Carcinoma1
Department of Toxicology, Tokyo Metropolitan Research Laboratory of Public Health 24-1, Hyakunincho 3-chome, Shinjuku-ku, Tokyo 169, Japan
Received May 20, 1992; accepted July 7, 1993
Male and female F344 rats (3033 rats/group) were administered piperonyl butoxide (
-[2-(2 butoxyethoxy)ethoxy]-4-,5-methylenedioxy-2-propyltoluene) in the diet at levels of 0 (control), 0.6, 1.2, and 2.4% for nearly 2 years. Beginning at about 40 weeks, 10 rats in the 1.2% treated male group died due to cecal hemorrhages. Piperonyl butoxide induced hepatocellular carcinoma in both sexes in a dose-dependent manner. Hepatocellular carcinoma was found even in the 1.2% treated male group (incidence, 26.7%), and incidences in the 2.4% groups of males and females were 80.0 and 57.7% respectively of all those surviving. Piperonyl butoxide also caused essential thrombo cythemia with a dose-response relationship. Hemorrhages in stomach and cecum, anemia, degenerative lesions of alveoli, and nephrotoxicity were also observed related to exposure. These results indicate that piperonyl butoxide is a hepatocarcinogen to the rat.